ClassID:

96740

C07K7/08 - page 6 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Recent Application in this class:
#1501
20190314476
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1502
20190314475
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1503
20190314447
2019-10-17

Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides

#1504
20190309325
2019-10-10

Methods and compositions for refining molybdenum mineral

#1505
20190309072
2019-10-10

ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHODS OF USE THEREOF

#1506
20190309038
2019-10-10

Engineered potent cytotoxic stapled BH3 peptides

#1507
20190309031
2019-10-10

Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies

#1508
20190309022
2019-10-10

Modulators of melanocortin receptors

#1509
20190309014
2019-10-10

PROCESS FOR PREPARATION OF ICATIBANT ACETATE

#1510
20190309013
2019-10-10

Linker molecule and use thereof in methods for purifying peptides

#1511
20190307836
2019-10-10

Heterotandem bicyclic peptide complexes

#1512
20190302117
2019-10-03

Universal kinase substrates and methods of use thereof

#1513
20190300930
2019-10-03

Lytic peptide biosensor and methods of making and using the same

#1514
20190300587
2019-10-03

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

#1515
20190300577
2019-10-03

Selectin inhibitors, composition, and uses related thereto

#1516
20190300576
2019-10-03

Solution-phase affinity selection of inhibitors from combinatorial peptide libraries

#1517
20190300575
2019-10-03

LYTIC PEPTIDE BIOSENSOR AND METHODS OF MAKING AND USING THE SAME

#1518
20190300574
2019-10-03

Anti-inflammatory nanofibers

#1519
20190300573
2019-10-03

HUMAN MYOSIN PEPTIDES

#1520
20190300572
2019-10-03

Anticancer peptides

#1521
20190293657
2019-09-26

Peptide, fluorescent probe comprising the same, and preparation method thereof

#1522
20190292226
2019-09-26

SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION

#1523
20190284256
2019-09-19

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1524
20190284238
2019-09-19

Antimicrobial peptoids with improved selectivity and use thereof

#1525
20190284237
2019-09-19

BIFUNCTIONAL PEPTIDE HAVING CAPABILITY TO REDUCE INFLAMMATION AND CAPABILITY TO FACILITATE DIFFERENTIATION OF STEM CELLS INTO CHONDROCYTES AND USE THEREOF

#1526
20190284236
2019-09-19

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1527
20190284235
2019-09-19

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1528
20190284232
2019-09-19

PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS

#1529
20190284207
2019-09-19

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

#1530
20190282688
2019-09-19

Hemagglutinin-binding peptide

#1531
20190282654
2019-09-19

Di-sulfide containing cell penetrating peptides and methods of making and using thereof

#1532
20190276505
2019-09-12

Antimicrobial peptides comprising epsilon lysine residues

#1533
20190276496
2019-09-12

FoxP3-binding peptides and uses thereof

#1534
20190276495
2019-09-12

EBOLA VIRUS VACCINE

#1535
20190275172
2019-09-12

Kinase and/or phosphatase sensing via hydroxyquinoline-sensitized chelates

#1536
20190275130
2019-09-12

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1537
20190275129
2019-09-12

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1538
20190275104
2019-09-12

Compositions and methods for cell delivery

#1539
20190274942
2019-09-12

Method of facilitating the bindings between keratinocytes

#1540
20190271689
2019-09-05

Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacy

#1541
20190270776
2019-09-05

Immunogenic WT-1 peptides and methods of use thereof

#1542
20190270771
2019-09-05

Peptides derived from the propeptide NTSR3 and their use in the treatment of depression

#1543
20190269803
2019-09-05

Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate

#1544
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

#1545
20190263867
2019-08-29

TAU PEPTIDES, METHODS OF MAKING, AND METHODS OF USING

#1546
20190263866
2019-08-29

Multimeric bicyclic peptide ligands

#1547
20190263862
2019-08-29

Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

#1548
20190263861
2019-08-29

Agonists of guanylate cyclase and their uses

#1549
20190262445
2019-08-29

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1550
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

#1551
20190262420
2019-08-29

COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

#1552
20190257830
2019-08-22

Detection and treatment of demyelinating diseases

#1553
20190256597
2019-08-22

Immunotherapy compositions and methods

#1554
20190256559
2019-08-22

PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF

#1555
20190255185
2019-08-22

High affinity CXCR4 selective binding conjugate and method for using the same

#1556
20190255155
2019-08-22

Butyrylcholinesterase zwitterionic polymer conjugates

#1557
20190255141
2019-08-22

GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES

#1558
20190248872
2019-08-15

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

#1559
20190248870
2019-08-15

NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS

#1560
20190248859
2019-08-15

Compositions comprising PEDF-derived short peptides and uses thereof

#1561
20190248849
2019-08-15

Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereof

#1562
20190248839
2019-08-15

Cell-penetrating compstatin analogs and uses thereof

#1563
20190248836
2019-08-15

DNA primase and gyrase inhibitors

#1564
20190248806
2019-08-15

ULK1 inhibitors and methods using same

#1565
20190247317
2019-08-15

ICAM-1 TARGETING ELPS

#1566
20190241652
2019-08-08

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#1567
20190241619
2019-08-08

Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy

#1568
20190241617
2019-08-08

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

#1569
20190241615
2019-08-08

CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS

#1570
20190241613
2019-08-08

Structure-based peptide inhibitors of alpha-synuclein aggregation

#1571
20190240360
2019-08-08

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

#1572
20190233520
2019-08-01

ANTI HLA-G SPECIFIC ANTIBODIES

#1573
20190233490
2019-08-01

Method of synthesizing antagonist peptides for cell growth

#1574
20190233483
2019-08-01

Antimicrobial peptides based on CMAP27

#1575
20190233475
2019-08-01

Polypeptide ligands specific for plasma kallikrein

#1576
20190231860
2019-08-01

Synthetic lipopeptide vaccines and immunotherapeutics

#1577
20190225711
2019-07-25

Therapeutic multi-targeting constructs and uses thereof

#1578
20190225660
2019-07-25

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#1579
20190225649
2019-07-25

Agents that activate CD47 and their use in the treatment of inflammation

#1580
20190225648
2019-07-25

Biologically active peptides

#1581
20190218539
2019-07-18

Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage

#1582
20190218511
2019-07-18

METHODS AND COMPOSITIONS FOR TARGETING PROGENITOR CELL LINES

#1583
20190218254
2019-07-18

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1584
20190218253
2019-07-18

Therapeutic spalt-like transcription factor 4 (SALL4) peptide

#1585
20190216907
2019-07-18

COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS

#1586
20190216901
2019-07-18

ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS

#1587
20190216884
2019-07-18

Extracellular histones as biomarkers for prognosis and molecular targets for therapy

#1588
20190216879
2019-07-18

PROTEIN INTERFACES

#1589
20190211317
2019-07-11

PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES

#1590
20190211316
2019-07-11

Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds

#1591
20190211062
2019-07-11

Modified proteins and methods of use thereof

#1592
20190204312
2019-07-04

Magnetic particle-binding peptides

#1593
20190202865
2019-07-04

Targeting dimerization of BAX to modulate BAX activity

#1594
20190202862
2019-07-04

Stapled and stitched polypeptides and uses thereof

#1595
20190202860
2019-07-04

Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient

#1596
20190201519
2019-07-04

Influenza peptides and compositions

#1597
20190201477
2019-07-04

Compositions and methods for the treatment of neurodamage

#1598
20190194275
2019-06-27

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

#1599
20190194256
2019-06-27

Solid state forms of linaclotide

#1600
20190194255
2019-06-27

Compositions and methods for modulating γ-c-cytokine activity

#1601
20190194254
2019-06-27

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

#1602
20190194252
2019-06-27

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

#1603
20190194249
2019-06-27

Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure

#1604
20190194246
2019-06-27

SOLID PHASE PEPTIDE SYNTHESIS

#1605
20190192677
2019-06-27

Conjugate of minoxidil and peptide

#1606
20190192669
2019-06-27

TLR9 targeted therapeutics

#1607
20190192638
2019-06-27

Anti-inflammatory peptides and compositions comprising the same

#1608
20190184025
2019-06-20

Bicyclic peptide ligands specific for EphA2

#1609
20190183968
2019-06-20

Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells

#1610
20190183965
2019-06-20

Methods and compositions comprising a C-terminal Bax peptide

#1611
20190183964
2019-06-20

FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF

#1612
20190178878
2019-06-13

Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds

#1613
20190177410
2019-06-13

Fusion protein comprising apelin and an anti-APLNR antibody

#1614
20190177383
2019-06-13

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1615
20190177370
2019-06-13

Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof

#1616
20190177369
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1617
20190177368
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1618
20190175689
2019-06-13

Chloride salt of TAT-NR2B9c

#1619
20190170746
2019-06-06

antigens

#1620
20190169621
2019-06-06

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

#1621
20190169234
2019-06-06

Peptide inhibitors of phosphoglycerate mutase and methods of use

#1622
20190169233
2019-06-06

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1623
20190169232
2019-06-06

C1q and HMGB1 fusion proteins and uses thereof

#1624
20190167812
2019-06-06

Nucleic acid condensing peptide, nucleic acid condensing peptide set, nucleic acid delivery carrier, nucleic acid delivery method, cell production method, cell detection method and kit

#1625
20190161518
2019-05-30

Pharmaceutical composition and the use thereof in the treatment of autoimmune diseases

#1626
20190160172
2019-05-30

Bone fracture repair by targeting of agents that promote bone healing

#1627
20190153232
2019-05-23

Ultra bright polymeric dyes with peptide backbones

#1628
20190153066
2019-05-23

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1629
20190153045
2019-05-23

Plant-derived elastin binding protein ligands and methods of using the same

#1630
20190153035
2019-05-23

PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF

#1631
20190153010
2019-05-23

Antibacterial sideromycins

#1632
20190152989
2019-05-23

ULK1 inhibitors and methods using same

#1633
20190151401
2019-05-23

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1634
20190144502
2019-05-16

Method for treating or/and preventing calcium deficiency-related diseases

#1635
20190142919
2019-05-16

PLIF MULTIMERIC PEPTIDES AND USES THEREOF

#1636
20190142898
2019-05-16

Peptides of syndecan-1 for inhibiting angiogenesis

#1637
20190142894
2019-05-16

Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same

#1638
20190142892
2019-05-16

Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxin of and use thereof

#1639
20190137512
2019-05-09

Reagents and methods for detecting protein crotonylation

#1640
20190135882
2019-05-09

Methods and systems for designing and/or characterizing soluble lipidated ligand agents

#1641
20190135864
2019-05-09

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

#1642
20190134213
2019-05-09

Bicyclic peptide-toxin conjugates specific for MT1-MMP

#1643
20190134147
2019-05-09

TFPI inhibitors and methods of use

#1644
20190128888
2019-05-02

Device for biological material detection, detection apparatus for biological material detection, method for measuring ion current, and method for identifying biological material

#1645
20190128873
2019-05-02

Methods to specifically profile protease activity at lymph nodes

#1646
20190125891
2019-05-02

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#1647
20190119370
2019-04-25

Methods of treatment using activatable anti-EGFR antibodies

#1648
20190119358
2019-04-25

Ras binding peptides and methods of use

#1649
20190119349
2019-04-25

PAR3 mimetic peptides and uses thereof

#1650
20190119340
2019-04-25

PEPTIDES AND NANOPARTICLE FORMULATIONS THEREOF

#1651
20190119328
2019-04-25

Modulation of complement activity

#1652
20190119327
2019-04-25

Selective delivery molecules and methods of use

#1653
20190119326
2019-04-25

CYCLIN A1-TARGETED T-CELL IMMUNOTHERAPY FOR CANCER

#1654
20190119325
2019-04-25

CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE

#1655
20190119321
2019-04-25

Peptide showing melanin generation-promoting activity and use thereof

#1656
20190119316
2019-04-25

NEW NUCLEOPHILE-REACTIVE SULFONATED COMPOUNDS FOR THE (RADIO)LABELLING OF (BIO)MOLECULES; PRECURSORS AND CONJUGATES THEREOF

#1657
20190117801
2019-04-25

PET-imaging immunomodulators

#1658
20190117725
2019-04-25

Inhibition of TREM receptor signaling with peptide variants

#1659
20190112350
2019-04-18

Peptidic TGF-beta antagonists

#1660
20190112336
2019-04-18

Peptide for skin regeneration or wound treatment and use thereof

#1661
20190112328
2019-04-18

Diarylsulfide backbone containing photolabile protecting groups

#1662
20190111165
2019-04-18

Sterilization and filtration of peptide compositions

#1663
20190111144
2019-04-18

Polyethylene glycol-modified angiogenesis inhibitor HM-1 and application thereof

#1664
20190111141
2019-04-18

Peptide with ability to penetrate cell membrane

#1665
20190106460
2019-04-11

BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN

#1666
20190100735
2019-04-04

Neurodegenerative disorders

#1667
20190100576
2019-04-04

SIGNAL BIOMARKERS

#1668
20190100557
2019-04-04

PROTRANSDUZIN B, A GENE TRANSFER ENHANCER

#1669
20190092824
2019-03-28

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1670
20190092821
2019-03-28

Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

#1671
20190092818
2019-03-28

CHIMERIC POLYPEPTIDES AND USES THEREOF

#1672
20190092816
2019-03-28

Stapled peptides and uses thereof

#1673
20190092814
2019-03-28

Peptide

#1674
20190092813
2019-03-28

Immunogenic WT-1 peptides and methods of use thereof

#1675
20190092812
2019-03-28

Cyclic peptide conjugates and methods of use

#1676
20190091344
2019-03-28

Amphipathic peptide

#1677
20190091284
2019-03-28

Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

#1678
20190086398
2019-03-21

Material and method to screen proteasome stimulators

#1679
20190085030
2019-03-21

D-enantiomeric peptides derived from D3 and use thereof

#1680
20190085029
2019-03-21

CYCLIN-DEPENDENT KINASE 5 (CDK5) INHIBITORY PEPTIDES

#1681
20190085028
2019-03-21

Synthetic peptides that modulate the NMDA receptor

#1682
20190083654
2019-03-21

Synthetic compound for improving efficiency of transfection

#1683
20190083570
2019-03-21

Peptides with anti-cancer activity

#1684
20190077834
2019-03-14

Compstatin analogs with improved pharmacokinetic properties

#1685
20190077833
2019-03-14

Cell penetrating peptides for intracellular delivery of molecules

#1686
20190077832
2019-03-14

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1687
20190077831
2019-03-14

Connective tissue stimulating peptides

#1688
20190076519
2019-03-14

Immunogenic rhinovirus peptides

#1689
20190076477
2019-03-14

Immunotherapy against neuronal and brain tumors

#1690
20190076476
2019-03-14

Immunotherapy against neuronal and brain tumors

#1691
20190071470
2019-03-07

ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF

#1692
20190071468
2019-03-07

PEPTIDE INHIBITORS OF SODIUM CHANNELS

#1693
20190070301
2019-03-07

Activated polyoxazolines and conjugates and compositions comprising the same

#1694
20190070263
2019-03-07

Modulating gamma-c-cytokine activity

#1695
20190069537
2019-03-07

Compositions and methods for reducing ice crystal formation

#1696
20190064145
2019-02-28

Method for determining the cell mediated immune competence of a subject

#1697
20190062747
2019-02-28

Polypeptide inhibitors of SMAD3 polypeptide activities

#1698
20190062404
2019-02-28

Composition and Method for Therapeutic Agent Delivery During Pregnancy

#1699
20190062376
2019-02-28

Treatments for Gastrointestinal Disorders

#1700
20190062375
2019-02-28

Composition for overcoming resistance to EGFR-targeting agent

#1701
20190062373
2019-02-28

METHOD OF GENERATING INTERACTING PEPTIDES

#1702
20190060433
2019-02-28

KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

#1703
20190060394
2019-02-28

Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging

#1704
20190056393
2019-02-21

METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT

#1705
20190055287
2019-02-21

Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use

#1706
20190055285
2019-02-21

Skin-penetrating peptide and method for using same

#1707
20190055278
2019-02-21

PROCESS FOR THE PREPARATION OF GUANYLATE CYCLASE 2C AGONIST

#1708
20190054138
2019-02-21

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#1709
20190048053
2019-02-14

Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant P53

#1710
20190048052
2019-02-14

ANTI-MICROBIAL PEPTIDES AND COATINGS

#1711
20190046654
2019-02-14

Albumin binding peptide conjugates and methods thereof

#1712
20190046652
2019-02-14

Cell penetrating peptides for intracellular delivery of molecules

#1713
20190046604
2019-02-14

LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS

#1714
20190046602
2019-02-14

Methods of treating acute myeloid leukemia

#1715
20190046601
2019-02-14

Peptides Having Anti-Inflammatory Properties

#1716
20190040103
2019-02-07

Proteinaceous compounds and uses therefor

#1717
20190038704
2019-02-07

EPHA4 cyclic peptide antagonists for neuroprotection and neural repair

#1718
20190037835
2019-02-07

Method for treating blood, blood products and organs

#1719
20190031718
2019-01-31

Methods for delivering cargo into a cell by using signal molecules as cell penetration agents

#1720
20190030149
2019-01-31

WT1 antigen peptide conjugate vaccine

#1721
20190030137
2019-01-31

Anti-inflammatory peptides and composition comprising the same

#1722
20190024094
2019-01-24

Peptide tag and tagged protein including same

#1723
20190023756
2019-01-24

EPHA2 t-cell epitope agonists and uses therefore

#1724
20190023755
2019-01-24

Compositions and methods of using islet neogenesis peptides and analogs thereof

#1725
20190023748
2019-01-24

D-peptide inhibitors of HIV entry and methods of use

#1726
20190023741
2019-01-24

Peptide exhibiting hydrolytic activity and use thereof

#1727
20190018014
2019-01-17

Peptides for targeting gastric cancer, and medical use tehreof

#1728
20190016758
2019-01-17

Potent Compstatin Analogs

#1729
20190016757
2019-01-17

Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

#1730
20190016756
2019-01-17

α4β7 thioether peptide dimer antagonists

#1731
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

#1732
20190010193
2019-01-10

Derivative Peptide Compounds and Methods of Use

#1733
20190010191
2019-01-10

Polypeptide expressed in the stratum corneum and use thereof

#1734
20190010190
2019-01-10

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

#1735
20190008929
2019-01-10

Fragments of P97 and uses thereof

#1736
20190002590
2019-01-03

Circular tandem repeat proteins

#1737
20190002505
2019-01-03

Peptide and use thereof

#1738
20190002504
2019-01-03

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1739
20190002503
2019-01-03

ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIVES

#1740
20190002502
2019-01-03

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#1741
20190002501
2019-01-03

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#1742
20190002500
2019-01-03

NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS

#1743
20190002499
2019-01-03

Peptides and nanoparticles for intracellular delivery of molecules

#1744
20190002498
2019-01-03

Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity

#1745
20190001003
2019-01-03

Manganese-based chelate conjugates for molecular MR imaging

#1746
20190000947
2019-01-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

#1747
20180372754
2018-12-27

Bladder cancer biomarker proteins

#1748
20180371103
2018-12-27

ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF

#1749
20180371071
2018-12-27

Therapeutic DLL4 Binding Proteins

#1750
20180371050
2018-12-27

Murine anti-NY-ESO-1 T cell receptors

#1751
20180371022
2018-12-27

Linaclotide synthesis method

#1752
20180371020
2018-12-27

Bicyclic peptide ligands with detectable moieties and uses thereof

#1753
20180371019
2018-12-27

Modulation of complement activity

#1754
20180371018
2018-12-27

POLYPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#1755
20180369158
2018-12-27

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

#1756
20180368459
2018-12-27

Dietary peptides

#1757
20180364219
2018-12-20

Protein detection method, and protein immunoassay method

#1758
20180362817
2018-12-20

Adhesive molecules

#1759
20180362587
2018-12-20

Compositions and Methods for Inhibiting CBP80 Binding to PGC1 Family of Co-Activators

#1760
20180362586
2018-12-20

Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

#1761
20180362585
2018-12-20

Modulation of structured polypeptide specificity

#1762
20180362584
2018-12-20

Peptides that target inflamed or distressed cardiac tissue and uses related thereto

#1763
20180360943
2018-12-20

LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE

#1764
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1765
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1766
20180360903
2018-12-20

Peptide having highly-shifted accumulation to pancreatic cancer cells and tissues, and use of said peptide

#1767
20180355015
2018-12-13

METHODS AND MATERIALS FOR GENERATING T CELLS

#1768
20180354993
2018-12-13

Cyclic NTCP-targeting peptides and their uses as entry inhibitors

#1769
20180354992
2018-12-13

Biosynthetic proline/alanine random coil polypeptides and their uses

#1770
20180353586
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1771
20180353585
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1772
20180353584
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1773
20180353583
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1774
20180346575
2018-12-06

PEPTIDES

#1775
20180346538
2018-12-06

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1776
20180346537
2018-12-06

ANTI-TUMOUR RESPONSE TO MODIFIED SELF-EPITOPES

#1777
20180346535
2018-12-06

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1778
20180346526
2018-12-06

Peptides having antimicrobial activity and new enzyme capable of converting L-configured residue in D-configured amino acid in a peptide

#1779
20180346517
2018-12-06

PEPTIDES

#1780
20180346516
2018-12-06

Peptides and uses therefor as antiviral agents

#1781
20180346513
2018-12-06

METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF

#1782
20180344867
2018-12-06

Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules

#1783
20180344861
2018-12-06

Peptide composition

#1784
20180344831
2018-12-06

Pharmaceutical composition for injection

#1785
20180344825
2018-12-06

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1786
20180344809
2018-12-06

Neuroprotective peptides derived from activity-dependent neuroprotective protein for treatment of neurological diseases

#1787
20180340188
2018-11-29

Transfection complexes and methods of using the same

#1788
20180340012
2018-11-29

METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM

#1789
20180339044
2018-11-29

PD-1 and CTLA-4 dual inhibitor peptides

#1790
20180339016
2018-11-29

Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof

#1791
20180339014
2018-11-29

PEPTIDOMIMETIC MACROCYCLES

#1792
20180339013
2018-11-29

Collagenase-derived peptides promote tissue regeneration and wound healing

#1793
20180334478
2018-11-22

Anti-hepatitis B virus X protein polypeptide pharmaceutical

#1794
20180334477
2018-11-22

NPR-B agonists

#1795
20180327749
2018-11-15

Antisense composition and method for treating muscle atrophy

#1796
20180327643
2018-11-15

Surfactant adhesive composition

#1797
20180327474
2018-11-15

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1798
20180327463
2018-11-15

Peptides

#1799
20180327456
2018-11-15

Selenium-based therapies

#1800
20180327448
2018-11-15

Purification method, purification kit, and silicon oxide-binding tag for use therein